NSN 6505-01-533-5267
Part Details | ESTRADIOL TRANSDERMAL SYSTEM
6505-01-533-5267
Alternate Parts: 051554, 05-1554, VIVELLEDOT, VIVELLE-DOT, NDC00078034345, NDC00078-0343-45, 6505-01-533-5267, 01-533-5267, 6505015335267, 015335267
Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
---|---|---|---|
65 | SEP 19, 2005 | 01-533-5267 | 38827 ( ESTRADIOL TRANSDERMAL SYSTEM ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-533-5267
Part Number | Cage Code | Manufacturer |
---|---|---|
05-1554 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
VIVELLE-DOT | 04520 | NOVARTIS PHARMACEUTICALS CORPORATIONDBA NPS |
NDC00078-0343-45 | 04520 | NOVARTIS PHARMACEUTICALS CORPORATIONDBA NPS |
Technical Data | NSN 6505-01-533-5267
Characteristic | Specifications |
---|---|
USUAL DOSE | 0.0375MG RELEASE PER 24 HOURS |
OVERALL STRENGTH IN SYSTEM | 0.585MG ESTRADIOL USP ACTIVE INGREDIENT |
SYSTEM SIZE | 3.75 SQUARE CENTIMETERS |
PROTECTIVE STORAGE FEATURE | CONTROLLED ROOM TEMPERATURE |
FEATURES PROVIDED | INDIVIDUALLY SEALED |
SPECIAL FEATURES | USED IN THE TREATMENT OF VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE AND PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS; 8 INDIVIDUAL SEALED PATCHES PER BOX, 3 BOXES PER PKG (TOTAL OF 24 PATCHES); DO NOT STORE UNPOUCHED, APPLY IMMEDIATELY UPON REMOVAL FROM THE PROTECTIVE POUCH; STORE AT CONTROLLED ROOM TEMPERATURE 25DEG C |
PART NAME ASSIGNED BY CONTROLLING AGENCY | ESTRADIOL TRANSDERMAL SYSTEM 0.0375MG/24 HOURS PATCH 8EA 3S |
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER | 681604 |